Skip to content
value.today
Total raised
$2 M
1 round on record
Latest round
$2 M
Jul 2026
First round on record
Jul 2026
Today
Private
No later event on record

Funding rounds

1 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of FluidForm Bio, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Jul 2026$2 MNo. 1Under $2 million

FluidForm Bio, Inc.: Raise no. 1, Jul 2026

Investors in this round

20 investors had bought by the notice of Aug 27, 2026: 20 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$2 M of $3 M offered; $1 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Adam Feinberg · Executive Officer, Director · Chief Technology Officer
  • Erik Waters · Executive Officer · Chief Financial Officer
  • Michael Graffeo · Executive Officer, Director · President and Chief Executive Officer

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Michael Graffeo, President and CEO. Source: SEC Form D, newest notice filed Aug 27, 2026. Read the notice at the SEC.

equity, optionsSEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • FluidForm Bio, Inc. reported revenue of $168,783 for its most recent fiscal year (filed Apr 2025), down from $1.95 million the year before.

    SEC Form C · Apr 2025

  • The direct cost of what it sold was $24,150, so 86% of its revenue was left after those costs.

    SEC Form C · Apr 2025

  • Net loss for the same year: $4.39 million.

    SEC Form C · Apr 2025

  • FluidForm Bio, Inc. chose not to state its revenue in its newest notice of a funding round (Aug 2026).

    SEC Form D · Aug 2026

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · Aug 2026

In its own words

How the company describes itself to search engines on its website, word for word.

“We build living human tissue using cells, proteins, and nothing else. Our technology leverages the intersection of personalized medicine, synthetic and computational biology, advanced materials, bioprinting, and AI to go from patient data to human tissue.”

Source: The company's website · as of Nov 15, 2026

Products and services#

No products or services on record: its website does not describe any in structured form (a page that declares itself a product or service), and Wikidata lists none.

Investors#

No investor of FluidForm Bio, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 1 round above had up to 20 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by FluidForm Bio, Inc.
NameRoleNamed in
Adam FeinbergChief Technology OfficerAug 2026
Erik WatersChief Financial OfficerAug 2026
Michael GraffeoPresident and Chief Executive OfficerAug 2026
Adam FeinbergChief Technology OfficerAug 2026
Michael GraffeoPresident and Chief Executive OfficerAug 2026